Kidney Cancer Trial, Recruiting NCT05519878 Sponsor: City of Hope Medical Center Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT05519878
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who are sufficiently fluent in English
  • People currently receiving active treatment such as chemotherapy, immunotherapy, hormonal therapy, or radiotherapy
  • People who have been diagnosed with a genitourinary cancer (such as prostate, kidney, or bladder cancer) and whose doctor has assessed their fatigue as mild to moderate (grade 1 or 2)
  • People whose doctor estimates they have a life expectancy of six months or more
  • People who are willing and able to give their own consent to participate
  • People who score 30 or below on a fatigue questionnaire called the FACIT-Fatigue scale during an initial screening

Who may not be able to join:

  • People with severe sleep disorders, such as narcolepsy
  • People with eye conditions that affect how light is processed, such as untreated cataracts, severe glaucoma, macular degeneration, blindness, pupil dilation problems, or other retinal disorders
  • People with severe psychological conditions, such as bipolar disorder or manic episodes
  • People who currently work night shifts
  • People who have previously used light therapy to manage fatigue or depressive symptoms
  • People who have had a second cancer diagnosis within the past five years
  • People who plan to travel across time zones during the treatment period
  • People who are pregnant
  • People who are currently recovering from eye surgery in the past six months that is causing eye irritation
  • People with sensitivity to light, epilepsy, or a history of seizures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 November 2022
Est. completion
25 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Functional Assessment of Cancer Therapy - (FACIT); Functional Assessment of Cancer Therapy - (FACIT); Functional Assessment of Cancer Therapy - (FACIT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov